Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 93.05 Million USD | 52.48% |
| 2023 | 61.02 Million USD | 110.43% |
| 2022 | 29 Million USD | -29.65% |
| 2021 | 41.22 Million USD | 40.42% |
| 2020 | 29.35 Million USD | -12.5% |
| 2019 | 33.55 Million USD | 27.26% |
| 2018 | 26.36 Million USD | -11.74% |
| 2017 | 29.87 Million USD | -28.81% |
| 2016 | 41.96 Million USD | 13.06% |
| 2015 | 37.11 Million USD | 9.57% |
| 2014 | 33.87 Million USD | 2.17% |
| 2013 | 33.15 Million USD | -25.51% |
| 2012 | 44.51 Million USD | -25.15% |
| 2011 | 59.46 Million USD | 40.5% |
| 2010 | 42.32 Million USD | -62.88% |
| 2009 | 114.02 Million USD | 28.73% |
| 2008 | 88.57 Million USD | 31.07% |
| 2007 | 67.58 Million USD | 1.65% |
| 2006 | 66.48 Million USD | 11.69% |
| 2005 | 59.52 Million USD | 27.46% |
| 2004 | 46.7 Million USD | 15.08% |
| 2003 | 40.58 Million USD | 51.4% |
| 2002 | 26.8 Million USD | 32.35% |
| 2001 | 20.25 Million USD | 15.09% |
| 2000 | 17.59 Million USD | 37.48% |
| 1999 | 12.8 Million USD | 37.63% |
| 1998 | 9.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 23.98 Million USD | 83.27% |
| 2024 Q3 | 21.02 Million USD | -12.33% |
| 2024 Q1 | 13.08 Million USD | 16.47% |
| 2023 Q1 | 6.92 Million USD | -14.87% |
| 2023 FY | 61.02 Million USD | 110.43% |
| 2023 Q3 | 34.33 Million USD | 302.18% |
| 2023 Q2 | 8.53 Million USD | 23.3% |
| 2023 Q4 | 11.23 Million USD | -67.27% |
| 2022 Q1 | 6.84 Million USD | -24.64% |
| 2022 Q2 | 7.28 Million USD | 6.49% |
| 2022 FY | 29 Million USD | -29.65% |
| 2022 Q3 | 6.73 Million USD | -7.53% |
| 2022 Q4 | 8.13 Million USD | 20.69% |
| 2021 FY | 41.22 Million USD | 40.42% |
| 2021 Q3 | 6.52 Million USD | -63.67% |
| 2021 Q2 | 17.95 Million USD | 133.97% |
| 2021 Q1 | 7.67 Million USD | 31.06% |
| 2021 Q4 | 9.08 Million USD | 39.24% |
| 2020 Q4 | 5.85 Million USD | -35.78% |
| 2020 Q1 | 7.27 Million USD | -42.45% |
| 2020 Q2 | 7.11 Million USD | -2.1% |
| 2020 FY | 29.35 Million USD | -12.5% |
| 2020 Q3 | 9.11 Million USD | 28.07% |
| 2019 Q3 | 7.65 Million USD | 27.06% |
| 2019 Q1 | 7.23 Million USD | 13.75% |
| 2019 Q2 | 6.02 Million USD | -16.65% |
| 2019 FY | 33.55 Million USD | 27.26% |
| 2019 Q4 | 12.63 Million USD | 64.96% |
| 2018 Q4 | 6.35 Million USD | -23.81% |
| 2018 FY | 26.36 Million USD | -11.74% |
| 2018 Q2 | 5.37 Million USD | -14.62% |
| 2018 Q1 | 6.29 Million USD | -10.49% |
| 2018 Q3 | 8.34 Million USD | 55.37% |
| 2017 FY | 29.87 Million USD | -28.81% |
| 2017 Q4 | 7.02 Million USD | 1.14% |
| 2017 Q3 | 6.94 Million USD | 3.21% |
| 2017 Q2 | 6.73 Million USD | -26.52% |
| 2017 Q1 | 9.16 Million USD | -8.48% |
| 2016 Q1 | 10.54 Million USD | 0.87% |
| 2016 Q3 | 12.5 Million USD | 40.39% |
| 2016 Q2 | 8.9 Million USD | -15.52% |
| 2016 Q4 | 10.01 Million USD | -19.92% |
| 2016 FY | 41.96 Million USD | 13.06% |
| 2015 Q3 | 9.88 Million USD | 22.63% |
| 2015 Q4 | 10.45 Million USD | 5.77% |
| 2015 Q1 | 8.72 Million USD | -2.98% |
| 2015 FY | 37.11 Million USD | 9.57% |
| 2015 Q2 | 8.05 Million USD | -7.68% |
| 2014 Q3 | 8.92 Million USD | 14.79% |
| 2014 Q1 | 8.18 Million USD | -2.14% |
| 2014 FY | 33.87 Million USD | 2.17% |
| 2014 Q2 | 7.77 Million USD | -4.96% |
| 2014 Q4 | 8.99 Million USD | 0.8% |
| 2013 Q3 | 8.29 Million USD | 3.94% |
| 2013 Q1 | 8.53 Million USD | -28.2% |
| 2013 Q4 | 8.35 Million USD | 0.83% |
| 2013 Q2 | 7.97 Million USD | -6.49% |
| 2013 FY | 33.15 Million USD | -25.51% |
| 2012 Q1 | 10.32 Million USD | -29.52% |
| 2012 FY | 44.51 Million USD | -25.15% |
| 2012 Q4 | 11.88 Million USD | 1.48% |
| 2012 Q3 | 11.7 Million USD | 10.5% |
| 2012 Q2 | 10.59 Million USD | 2.61% |
| 2011 FY | 59.46 Million USD | 40.5% |
| 2011 Q3 | 16.26 Million USD | 6.92% |
| 2011 Q2 | 15.21 Million USD | 13.99% |
| 2011 Q4 | 14.65 Million USD | -9.92% |
| 2011 Q1 | 13.34 Million USD | 76.85% |
| 2010 FY | 42.32 Million USD | -62.88% |
| 2010 Q3 | 16.22 Million USD | 2.11% |
| 2010 Q4 | 7.54 Million USD | -53.48% |
| 2010 Q2 | 15.88 Million USD | 2.99% |
| 2010 Q1 | 15.42 Million USD | -47.4% |
| 2009 Q3 | 8.57 Million USD | -19.16% |
| 2009 Q1 | 61.7 Million USD | 198.58% |
| 2009 Q2 | 10.6 Million USD | -82.82% |
| 2009 FY | 114.02 Million USD | 28.73% |
| 2009 Q4 | 29.32 Million USD | 242.1% |
| 2008 Q1 | 21.04 Million USD | 10.13% |
| 2008 FY | 88.57 Million USD | 31.07% |
| 2008 Q4 | 20.66 Million USD | -8.17% |
| 2008 Q3 | 22.5 Million USD | -4.46% |
| 2008 Q2 | 23.55 Million USD | 11.91% |
| 2007 Q1 | 15.65 Million USD | -5.78% |
| 2007 FY | 67.58 Million USD | 1.65% |
| 2007 Q4 | 19.11 Million USD | 15.51% |
| 2007 Q3 | 16.54 Million USD | 1.69% |
| 2007 Q2 | 16.27 Million USD | 3.94% |
| 2006 FY | 66.48 Million USD | 11.69% |
| 2006 Q1 | 15.78 Million USD | 2.98% |
| 2006 Q2 | 16.83 Million USD | 6.68% |
| 2006 Q3 | 17.24 Million USD | 2.43% |
| 2006 Q4 | 16.61 Million USD | -3.67% |
| 2005 FY | 59.52 Million USD | 27.46% |
| 2005 Q4 | 15.32 Million USD | -2.84% |
| 2005 Q3 | 15.77 Million USD | 5.34% |
| 2005 Q2 | 14.97 Million USD | 11.35% |
| 2005 Q1 | 13.44 Million USD | 5.61% |
| 2004 FY | 46.7 Million USD | 15.08% |
| 2004 Q4 | 12.73 Million USD | 19.77% |
| 2004 Q1 | 11.35 Million USD | -4.83% |
| 2004 Q2 | 11.98 Million USD | 5.59% |
| 2004 Q3 | 10.63 Million USD | -11.3% |
| 2003 Q3 | 12.23 Million USD | 36.59% |
| 2003 Q2 | 8.95 Million USD | 20.08% |
| 2003 Q1 | 7.46 Million USD | -6.36% |
| 2003 Q4 | 11.92 Million USD | -2.53% |
| 2003 FY | 40.58 Million USD | 51.4% |
| 2002 FY | 26.8 Million USD | 32.35% |
| 2002 Q4 | 7.96 Million USD | 15.09% |
| 2002 Q3 | 6.92 Million USD | 7.83% |
| 2002 Q2 | 6.42 Million USD | 16.85% |
| 2002 Q1 | 5.49 Million USD | -12.25% |
| 2001 Q1 | 4.58 Million USD | -13.91% |
| 2001 FY | 20.25 Million USD | 15.09% |
| 2001 Q4 | 6.26 Million USD | 24.8% |
| 2001 Q3 | 5.01 Million USD | -2.36% |
| 2001 Q2 | 5.13 Million USD | 12.06% |
| 2000 Q2 | 4.3 Million USD | 10.31% |
| 2000 Q1 | 3.9 Million USD | 50.0% |
| 2000 FY | 17.59 Million USD | 37.48% |
| 2000 Q4 | 5.32 Million USD | 32.62% |
| 2000 Q3 | 4.01 Million USD | -6.65% |
| 1999 Q1 | 2.8 Million USD | 12.0% |
| 1999 Q3 | 3.9 Million USD | 11.43% |
| 1999 Q2 | 3.5 Million USD | 25.0% |
| 1999 FY | 12.8 Million USD | 37.63% |
| 1999 Q4 | 2.6 Million USD | -33.33% |
| 1998 FY | 9.3 Million USD | 0.0% |
| 1998 Q4 | 2.5 Million USD | -3.85% |
| 1998 Q2 | 2.6 Million USD | 36.84% |
| 1998 Q1 | 1.9 Million USD | 0.0% |
| 1998 Q3 | 2.6 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -3549.098% |
| BrainsWay Ltd. | 23.09 Million USD | -302.98% |
| Cerus Corporation | 86.4 Million USD | -7.699% |
| Envoy Medical, Inc. | -473 Thousand USD | 19772.727% |
| electroCore, Inc. | 13.22 Million USD | -603.554% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -152444.262% |
| IceCure Medical Ltd | 1.3 Million USD | -7057.846% |
| Inogen, Inc. | 126.69 Million USD | 26.557% |
| OrthoPediatrics Corp. | 111.25 Million USD | 16.36% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 1638.05% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 196677.658% |
| MaxCyte, Inc. | 36.54 Million USD | -154.616% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -20283.031% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -109295.721% |
| Orthofix Medical Inc. | 486.27 Million USD | 80.864% |
| PAVmed Inc | -3.96 Million USD | 2445.06% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 1796.481% |
| RxSight, Inc. | 53.76 Million USD | -73.072% |
| Sight Sciences, Inc. | 69.17 Million USD | -34.517% |
| SI-BONE, Inc. | 109.42 Million USD | 14.959% |
| TELA Bio, Inc. | 40.11 Million USD | -131.98% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 38.756% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -1025.039% |
| Acutus Medical, Inc. | -3.13 Million USD | 3066.274% |
| Talis Biomedical Corporation | 371 Thousand USD | -24981.402% |
| Spectral AI, Inc. | 7.88 Million USD | -1080.863% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 1511.59% |
| CVRx, Inc. | 33.03 Million USD | -181.643% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -12482.654% |
| Bioventus Inc. | 328.19 Million USD | 71.647% |
| Venus Concept Inc. | 52.16 Million USD | -78.373% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -485.012% |
| LivaNova PLC | 771.25 Million USD | 87.935% |
| 908 Devices Inc. | 25.32 Million USD | -267.475% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 70.003% |
| Nemaura Medical Inc. | -1.47 Million USD | 6402.662% |
| NeuroPace, Inc. | 48.12 Million USD | -93.367% |
| LENSAR, Inc. | 21.1 Million USD | -340.858% |
| Apyx Medical Corporation | 14.12 Million USD | -558.915% |
| Cutera, Inc. | 41.49 Million USD | -124.254% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -404.046% |
| BioSig Technologies, Inc. | 18 Thousand USD | -516855.556% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 9.735% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -583.502% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 89.526% |
| Axonics, Inc. | 274.55 Million USD | 66.108% |
| Outset Medical, Inc. | 29 Million USD | -220.869% |
| IRIDEX Corporation | 21.8 Million USD | -326.707% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -30.969% |
| IRadimed Corporation | 50.15 Million USD | -85.517% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -32322.3% |
| INVO Bioscience, Inc. | 1.08 Million USD | -8467.235% |
| Telesis Bio, Inc. | 16.95 Million USD | -448.979% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 17.495% |
| Varex Imaging Corporation | 256.9 Million USD | 63.779% |
| Quipt Home Medical Corp. | 163.84 Million USD | 43.207% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 23019.212% |
| Pulmonx Corporation | 50.75 Million USD | -83.346% |
| Dynatronics Corporation | 7.63 Million USD | -1118.759% |
| Modular Medical, Inc. | -768 Thousand USD | 12216.146% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -1577.217% |
| Semler Scientific, Inc. | 61.2 Million USD | -52.046% |
| InMode Ltd. | 411.34 Million USD | 77.378% |
| Bruker Corporation | 1.51 Billion USD | 93.865% |
| Cytosorbents Corporation | 22.39 Million USD | -315.559% |
| DexCom, Inc. | 2.28 Billion USD | 95.935% |
| Align Technology, Inc. | 2.71 Billion USD | 96.577% |
| Viveve Medical, Inc. | 620 Thousand USD | -14908.387% |
| ZimVie Inc. | 290.38 Million USD | 67.955% |
| Movano Inc. | -158 Thousand USD | 58993.671% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 14.964% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -109295.721% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 74.693% |
| Profound Medical Corp. | 4.51 Million USD | -1961.399% |
| Insulet Corporation | 1.15 Billion USD | 91.978% |
| enVVeno Medical Corporation | -546 Thousand USD | 17142.491% |
| iCAD, Inc. | 14.53 Million USD | -540.149% |
| Nuwellis, Inc. | 4.98 Million USD | -1767.389% |
| Biotricity, Inc. | 8.35 Million USD | -1013.558% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 71.956% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 26015.662% |
| InspireMD, Inc. | 1.8 Million USD | -5049.53% |
| PAVmed Inc. | -3.96 Million USD | 2445.06% |
| BIOLASE, Inc. | 16.72 Million USD | -456.398% |
| Beyond Air, Inc. | -1.3 Million USD | 7219.51% |
| FONAR Corporation | 45.14 Million USD | -106.141% |
| AxoGen, Inc. | 127.87 Million USD | 27.231% |
| Vivani Medical, Inc. | -357 Thousand USD | 26164.986% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 52.314% |
| Inari Medical, Inc. | 434.56 Million USD | 78.587% |
| UFP Technologies, Inc. | 112.22 Million USD | 17.084% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -743186.205% |
| Tenon Medical, Inc. | 1.24 Million USD | -7398.147% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 114979.012% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -3442.019% |
| AdaptHealth Corp. | 479.56 Million USD | 80.597% |
| Sintx Technologies, Inc. | 1.84 Million USD | -4948.942% |
| NanoVibronix, Inc. | 1.53 Million USD | -5954.131% |
| Quanterix Corporation | 70.64 Million USD | -31.716% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 23019.212% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -561.821% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -76.302% |
| TransMedics Group, Inc. | 154.09 Million USD | 39.613% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -1989.647% |
| NeuroMetrix, Inc. | 3.94 Million USD | -2257.291% |
| Hyperfine, Inc. | 4.75 Million USD | -1856.107% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 13.017% |
| Biomerica, Inc. | 611 Thousand USD | -15129.46% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -123.214% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 12015.155% |
| Silk Road Medical, Inc | 127.08 Million USD | 26.78% |